根据您提供的文献内容，我将提取相关信息并按照您指定的JSON格式进行组织。以下是提取和标准化后的信息：

```json
{
    "Variants Include": [
        {
            "Gene": "PINK1",
            "variants": [
                {
                    "HGVS": "NM_032488.4:c.925G>A",
                    "cDNA Change": {
                        "transcript": "NM_032488.4",
                        "ref": "G",
                        "alt": "A",
                        "position": "925"
                    },
                    "Protein Change": {
                        "ref": "G",
                        "alt": "D",
                        "position": "309"
                    },
                    "Description in input context": "c.925G>A (p.G309D)"
                },
                {
                    "HGVS": "NM_032488.4:c.1040C>T",
                    "cDNA Change": {
                        "transcript": "NM_032488.4",
                        "ref": "C",
                        "alt": "T",
                        "position": "1040"
                    },
                    "Protein Change": {
                        "ref": "L",
                        "alt": "P",
                        "position": "347"
                    },
                    "Description in input context": "c.1040C>T (p.L347P)"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Recessive Parkinsonism",
        "MONDO": "MONDO:0005069"
    },
    "Experiment Method": [
        {
            "Assay Method": "Autophosphorylation Assay",
            "Material used": {
                "Material Source": "Escherichia coli BL21(DE3)",
                "Material Name": "GST-PINK1 fusion proteins",
                "Description": "PINK1 fusion proteins were expressed in Escherichia coli BL21(DE3) cells."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_032488.4:c.925G>A",
                    "Conclusion": "Moderately Decreased Activity",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "G309D had somewhat decreased activity (60.5% of wild type; P = 0.01)."
                },
                {
                    "Variant": "NM_032488.4:c.1040C>T",
                    "Conclusion": "Drastically Decreased Activity",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "L347P had drastically decreased activity (<10% of wild type)."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Data are representative of more than two experiments for each construct."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type PINK1 was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Artificial kinase-dead mutants (K219A, D362A, D384A) were used as negative controls."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "Yes",
                "Counts": "2"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "No",
                "Counts": "0"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "ANOVA with Fisher’s PLSD post hoc test"
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Activity greater than 80%",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Activity less than 50%",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Subcellular Fractionation",
            "Material used": {
                "Material Source": "COS-7 cells",
                "Material Name": "COS-7 cells transfected with C-terminal or N-terminal GFP-tagged PINK1",
                "Description": "COS-7 cells were transfected with C-terminal or N-terminal GFP-tagged PINK1."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_032488.4:c.925G>A",
                    "Conclusion": "Normal Localization",
                    "Molecular Effect": "No Effect",
                    "Result Description": "G309D PINK1 appeared to be normally localized."
                },
                {
                    "Variant": "NM_032488.4:c.1040C>T",
                    "Conclusion": "Decreased Protein Levels",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "L347P PINK1 gave much lower levels of immunostaining, especially for the C-terminal constructs."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Data are representative of more than two experiments for each construct."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type PINK1 was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Untransfected cells were used as a negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "Yes",
                "Counts": "2"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "No",
                "Counts": "0"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Protein levels similar to wild-type",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Protein levels significantly lower than wild-type",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}
```

### 解释
1. **变体信息**：提取了两个主要变体 `G309D` 和 `L347P` 的详细信息，并通过API标准化了HGVS命名法。
2. **疾病描述**：识别出文献中研究的疾病为“隐性帕金森病”，并从MONDO数据库检索了对应的术语。
3. **实验方法**：列出了文献中提到的所有实验方法（如自磷酸化测定、亚细胞分级），并提取了每种方法的详细信息，包括材料来源、读出类型、结果描述等。
4. **标准化和审批**：确定了实验方法是否通常用于研究该疾病，并根据文献内容或专业知识设定了正常和异常结果的阈值。

如果您有其他具体需求或需要进一步调整，请告知！